NCT06269614

Brief Summary

Using a metabolomics approach in combination with eye-tracking data, this research study proposes to gather evidence from two interrelated body systems (gut and brain) in order to assess how the microbiome is involved in stress modulated symptoms in children with autism and children exposed to repeated stress in comparison to a control group.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2023Dec 2027

Study Start

First participant enrolled

January 12, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

5 years

First QC Date

December 11, 2023

Last Update Submit

February 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Enteric Microbiome abundance

    Increase in gut microbiome abundance (from stool samples) based on values from statistical methods, Analysis of Variance to compare differential abundance analysis.

    4 weeks

  • Enteric Microbiome diversity

    Increase in gut microbiome diversity in the number of beneficial bacteria in the gut (from stool samples) as measured by α-diversity measures using plot\_anova\_diversity function in microbiomeSeq package.

    4 weeks

Secondary Outcomes (2)

  • Improved response to stressor

    4 weeks

  • Improved physiological response to stressor

    4 weeks

Study Arms (2)

Probiotic Treatment

EXPERIMENTAL

Pediatric Probiotic Treatment

Dietary Supplement: Probiotic

No Probiotic Treatment

NO INTERVENTION

No intervention

Interventions

ProbioticDIETARY_SUPPLEMENT

Consumption of probiotic with parent- as tolerated for 4 weeks.

Probiotic Treatment

Eligibility Criteria

Age4 Years - 95 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children diagnosed with Autism
  • Children with neurotypical development
  • Children in foster care
  • Children in homeless shelters
  • Children 4-7 years old
  • Must be able to watch a short video
  • Must be able to consume children's powder probiotics for 4 weeks

You may not qualify if:

  • Children younger than 4, and older than 7.9 years old.
  • Inability to watch a screen
  • severe cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nova Southeastern University College of Nursing

Davie, Florida, 33314, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderFractures, Stress

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersFractures, BoneWounds and Injuries

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Gesulla Cavanaugh, PhD

    Nova Southeastern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Dean of Research and Assessment

Study Record Dates

First Submitted

December 11, 2023

First Posted

February 21, 2024

Study Start

January 12, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Data will be shared based on institutional and IRB approval

Locations